DrugPatentWatch Database Preview
Details for Biologics License Application: 103132
Email this page to a colleague
» See Plans and PricingSummary for BLA: 103132
| Tradename: | INTRON A |
| Applicant: | Schering |
| Ingredient: | interferon alfa-2b |
| Patents: | 1260 |
| Approval Date: | Jun 04, 1986 |
| Suppliers: see list | 1 |
Pharmacology for BLA: 103132
| Ingredient-type | Interferon Alfa-2b Interferon-alpha |
| Drug Class | Interferon alpha |
US Patents for BLA: 103132
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | IDENIX PHARMACEUTICALS LLC (Cambridge, MA) | 2039-02-26 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Cipla Limited (Mumbia, IN) | 2035-12-09 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
